JPWO2020028275A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020028275A5
JPWO2020028275A5 JP2021505349A JP2021505349A JPWO2020028275A5 JP WO2020028275 A5 JPWO2020028275 A5 JP WO2020028275A5 JP 2021505349 A JP2021505349 A JP 2021505349A JP 2021505349 A JP2021505349 A JP 2021505349A JP WO2020028275 A5 JPWO2020028275 A5 JP WO2020028275A5
Authority
JP
Japan
Prior art keywords
amino acid
polypeptide
acid sequence
seq
substitution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021505349A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021531814A (ja
JP2021531814A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/043977 external-priority patent/WO2020028275A1/en
Publication of JP2021531814A publication Critical patent/JP2021531814A/ja
Publication of JPWO2020028275A5 publication Critical patent/JPWO2020028275A5/ja
Publication of JP2021531814A5 publication Critical patent/JP2021531814A5/ja
Priority to JP2024095641A priority Critical patent/JP2024137947A/ja
Ceased legal-status Critical Current

Links

JP2021505349A 2018-07-30 2019-07-29 インターフェロン−ガンマバイアス型アゴニスト Ceased JP2021531814A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024095641A JP2024137947A (ja) 2018-07-30 2024-06-13 インターフェロン－ガンマバイアス型アゴニスト

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862712128P 2018-07-30 2018-07-30
US62/712,128 2018-07-30
PCT/US2019/043977 WO2020028275A1 (en) 2018-07-30 2019-07-29 Interferon-gamma biased agonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024095641A Division JP2024137947A (ja) 2018-07-30 2024-06-13 インターフェロン－ガンマバイアス型アゴニスト

Publications (3)

Publication Number Publication Date
JP2021531814A JP2021531814A (ja) 2021-11-25
JPWO2020028275A5 true JPWO2020028275A5 (https=) 2022-08-08
JP2021531814A5 JP2021531814A5 (https=) 2022-08-08

Family

ID=69230882

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021505349A Ceased JP2021531814A (ja) 2018-07-30 2019-07-29 インターフェロン−ガンマバイアス型アゴニスト
JP2024095641A Pending JP2024137947A (ja) 2018-07-30 2024-06-13 インターフェロン－ガンマバイアス型アゴニスト

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024095641A Pending JP2024137947A (ja) 2018-07-30 2024-06-13 インターフェロン－ガンマバイアス型アゴニスト

Country Status (7)

Country Link
US (1) US12410226B2 (https=)
EP (1) EP3830115A4 (https=)
JP (2) JP2021531814A (https=)
AU (1) AU2019313339A1 (https=)
CA (1) CA3108066A1 (https=)
MX (1) MX2021001165A (https=)
WO (1) WO2020028275A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020028275A1 (en) 2018-07-30 2020-02-06 The Board Of Trustees Of The Leland Stanford Junior University Interferon-gamma biased agonists
WO2022212525A2 (en) 2021-03-30 2022-10-06 City Of Hope Car t cell therapy and ifn gamma

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JPS6124599A (ja) * 1984-07-11 1986-02-03 Kyowa Hakko Kogyo Co Ltd 新規ヒトインタ−フエロン−ｒポリペプチド誘導体
US4845196A (en) 1985-06-24 1989-07-04 G. D. Searle & Co. Modified interferon gammas
JP2969461B2 (ja) 1988-07-23 1999-11-02 株式会社林原生物化学研究所 ヒトγ−インターフェロンとその製造方法並びに用途
US5858784A (en) 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
DE19535853C2 (de) * 1995-09-18 1999-04-01 Fraunhofer Ges Forschung Varianten des rekombinanten humanen Interferon-gamma, Verfahren zu ihrer Herstellung und ihre Verwendung
SK8292002A3 (en) 1999-11-12 2002-12-03 Maxygen Holdings Ltd A conjugate exhibiting interferon gamma activity, nucleotide sequence encoding for a polypeptide fraction of conjugate, an expression vector and a host cell containing nucleotide sequence, pharmaceutical composition comprising the same and use thereof
US7038015B2 (en) * 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
JP2004522803A (ja) 2001-06-29 2004-07-29 マキシゲン・エイピーエス インターフェロン製剤
AU2003239774A1 (en) * 2002-07-03 2004-01-23 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
EP1877434A2 (en) * 2005-05-04 2008-01-16 Nautilus Biotech Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
US8617531B2 (en) 2006-12-14 2013-12-31 Bolder Biotechnology, Inc. Methods of making proteins and peptides containing a single free cysteine
US20080260820A1 (en) * 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides
CA2809747C (en) 2010-08-30 2018-05-01 Roberto Testi Compositions and methods for treating friedreich's ataxia with interferon gamma
US10466359B2 (en) * 2013-01-01 2019-11-05 Inuitive Ltd. Method and system for light patterning and imaging
CA3040802A1 (en) 2016-10-24 2018-05-03 Orionis Biosciences Nv Targeted mutant interferon-gamma and uses thereof
WO2020028275A1 (en) 2018-07-30 2020-02-06 The Board Of Trustees Of The Leland Stanford Junior University Interferon-gamma biased agonists
EP3883585A4 (en) 2018-11-20 2022-12-14 Innovative Cellular Therapeutics Holdings, Ltd. MODIFIED CELL EXPRESSING THERAPEUTIC AND USES THEREOF

Similar Documents

Publication Publication Date Title
US20210177983A1 (en) SINGLE CHAIN Fc FUSION PROTEINS
ES2356620T3 (es) Reducción de la inmunogenicidad de las proteínas de fusión.
RU2711979C2 (ru) Белковый комплекс интерлейкина 15 и его применение
JP2017529059A5 (https=)
JP2020511949A5 (https=)
IL308851B1 (en) T cell modulatory multimeric polypeptides and methods of using them
CN101588820A (zh) α-乳清蛋白组合物
JP2017519491A5 (https=)
CN120242030A (zh) 将白细胞介素-10用于治疗疾病和病症的方法
JP2012520059A5 (https=)
AU2020207265A1 (en) Multi-functional fusion proteins and uses thereof
CN111315398A (zh) 白介素-10与免疫检查点途径抑制剂的组合的组合物和使用方法
CN102906120A (zh) 重组人g-csf二聚体及其在治疗神经系统疾病中的用途
WO2023143463A1 (en) Fusion protein and application thereof
JPWO2018234492A5 (https=)
ES2290156T3 (es) Vector de expresion y secrecion del alfa interferon humano y procedimiento para producir alfa interferon humano empleando el anterior.
JP2021531814A5 (https=)
JPWO2020028275A5 (https=)
JP2019518713A5 (https=)
TWI905155B (zh) 包含 il-2蛋白及cd80蛋白片段或其變異體的融合蛋白及其用途
JP2023550191A (ja) Ｄｒ４および／またはｄｒ５を標的とするポリペプチドならびに関連する組成物および方法
JPWO2021229076A5 (https=)
WO2023143464A1 (en) Fusion protein and application thereof
CN102574907B (zh) 修饰的人肿瘤坏死因子受体i多肽或其片段以及制备它们的方法
JPWO2022129560A5 (https=)